Lifecore Biomedical, Inc. Common Stock (LFCR)
PHARMACEUTICAL PREPARATIONS
Lifecore Biomedical, Inc. Common Stock (LFCR) is listed on Nasdaq, where it has traded since February 15, 1996.
- Listed On
- Nasdaq
- Listed Since
- February 15, 1996
- Employees
- 382
- Market Cap
- $159M
About Lifecore Biomedical, Inc. Common Stock
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 96 institutions reported holding LFCR, with 25.4 million shares worth $133.3 million in aggregate. The largest reported holder was Wynnefield Capital, with 4.7 million shares worth $24.7 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Wynnefield Capital | 4,703,216 | $25M | Unchanged |
| Legion Partners Asset Management | 4,461,823 | $23M | Unchanged |
| Greenhaven Road Investment Management, | 3,190,769 | $17M | Reduced 9.8% |
| 325 Capital | 2,895,881 | $15M | Added 33.92% |
| BlackRock | 2,013,093 | $11M | Added 7.23% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is LFCR?
Lifecore Biomedical, Inc. Common Stock (LFCR) is listed on Nasdaq, where it has traded since February 15, 1996.
Who are the largest institutional holders of LFCR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of LFCR were Wynnefield Capital, Legion Partners Asset Management and Greenhaven Road Investment Management,.
How many institutions own LFCR?
96 institutions reported a position in LFCR for the quarter ended June 30, 2026, worth $133.3 million in total.
Did institutions buy or sell LFCR last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for LFCR.
Every reported institutional holder, plus insider and congressional trades in LFCR, on SentiSense.